| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30065325 | HIV | ENSG00000185760.18 | protein_coding | KCNQ5 | No | No | 56479 | Q9NR82 |
| TVIS30065326 | HIV | ENSG00000185760.18 | protein_coding | KCNQ5 | No | No | 56479 | Q9NR82 |
| TVIS30065327 | HIV | ENSG00000185760.18 | protein_coding | KCNQ5 | No | No | 56479 | Q9NR82 |
| TVIS30065328 | HIV | ENSG00000185760.18 | protein_coding | KCNQ5 | No | No | 56479 | Q9NR82 |
| TVIS30065329 | HIV | ENSG00000185760.18 | protein_coding | KCNQ5 | No | No | 56479 | Q9NR82 |
| TVIS20002390 | HPV | ENSG00000185760.18 | protein_coding | KCNQ5 | No | No | 56479 | Q9NR82 |
| TVIS20008498 | HPV | ENSG00000185760.18 | protein_coding | KCNQ5 | No | No | 56479 | Q9NR82 |
| TVIS20007600 | HPV | ENSG00000185760.18 | protein_coding | KCNQ5 | No | No | 56479 | Q9NR82 |
| TVIS20007601 | HPV | ENSG00000185760.18 | protein_coding | KCNQ5 | No | No | 56479 | Q9NR82 |
| TVIS20006284 | HPV | ENSG00000185760.18 | protein_coding | KCNQ5 | No | No | 56479 | Q9NR82 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | KCNQ5 |
|---|---|
| DrugBank ID | DB04953 |
| Drug Name | Ezogabine |
| Target ID | BE0002400 |
| UniProt ID | Q9NR82 |
| Regulation Type | |
| PubMed IDs | 17184917; 12545144; 16713428 |
| Citations | Hirano K, Kuratani K, Fujiyoshi M, Tashiro N, Hayashi E, Kinoshita M: Kv7.2-7.5 voltage-gated potassium channel (KCNQ2-5) opener, retigabine, reduces capsaicin-induced visceral pain in mice. Neurosci Lett. 2007 Feb 14;413(2):159-62. Epub 2006 Dec 20.@@Hermann R, Ferron GM, Erb K, Knebel N, Ruus P, Paul J, Richards L, Cnota HP, Troy S: Effects of age and sex on the disposition of retigabine. Clin Pharmacol Ther. 2003 Jan;73(1):61-70.@@Borlak J, Gasparic A, Locher M, Schupke H, Hermann R: N-Glucuronidation of the antiepileptic drug retigabine: results from studies with human volunteers, heterologously expressed human UGTs, human liver, kidney, and liver microsomal membranes of Crigler-Najjar type II. Metabolism. 2006 Jun;55(6):711-21. |
| Groups | Approved; Investigational |
| Direct Classification | Phenylbenzamines |
| SMILES | CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1 |
| Pathways | |
| PharmGKB | PA144997862 |
| ChEMBL | CHEMBL41355 |
